|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.Erratum in: CA
Cancer J Clin 70: 313, 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nagini S: Breast Cancer: Current Molecular
Therapeutic Targets and New Players. Anticancer Agents Med Chem.
17:152–163. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wilusz JE and Sharp PA: Molecular biology.
A circuitous route to noncoding RNA. Science. 340:440–441. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ashwal-Fluss R, Meyer M, Pamudurti NR,
Ivanov A, Bartok O, Hanan M, Evantal N, Memczak S, Rajewsky N and
Kadener S: circRNA biogenesis competes with pre-mRNA splicing. Mol
Cell. 56:55–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jahani S, Nazeri E, Majidzadeh-A K, Jahani
M and Esmaeili R: Circular RNA; a new biomarker for breast cancer:
A systematic review. J Cell Physiol. 235:5501–5510. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu J, Jiang Z, Chen C, Hu Q, Fu Z, Chen J,
Wang Z, Wang Q, Li A, Marks JR, et al: CircIRAK3 sponges miR-3607
to facilitate breast cancer metastasis. Cancer Lett. 430:179–192.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang N, Gu Y, Li L, Wang F, Lv P, Xiong Y
and Qiu X: Circular RNA circMYO9B facilitates breast cancer cell
proliferation and invasiveness via upregulating FOXP4 expression by
sponging miR-4316. Arch Biochem Biophys. 653:63–70. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shibuya N, Kakeji Y and Shimono Y:
MicroRNA-93 targets WASF3 and functions as a metastasis suppressor
in breast cancer. Cancer Sci. 111:2093–2103. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Malagobadan S, Ho CS and Nagoor NH:
MicroRNA-6744-5p promotes anoikis in breast cancer and directly
targets NAT1 enzyme. Cancer Biol Med. 17:101–111. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ahuja N, Schwer B, Carobbio S, Waltregny
D, North BJ, Castronovo V, Maechler P and Verdin E: Regulation of
insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase.
J Biol Chem. 282:33583–33592. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sebastián C, Satterstrom FK, Haigis MC and
Mostoslavsky R: From sirtuin biology to human diseases: An update.
J Biol Chem. 287:42444–42452. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li T, Li Y, Liu T, Hu B, Li J, Liu C, Liu
T and Li F: Mitochondrial PAK6 inhibits prostate cancer cell
apoptosis via the PAK6-SIRT4-ANT2 complex. Theranostics.
10:2571–2586. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Z, Li H, Zhao ZB, Zhu W, Feng PP, Zhu
XW and Gong JP: SIRT4 silencing in tumor-associated macrophages
promotes HCC development via PPARδ signalling-mediated alternative
activation of macrophages. J Exp Clin Cancer Res. 38:4692019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y, Guo Y, Gao J and Yuan X:
Tumor-suppressive function of SIRT4 in neuroblastoma through
mitochondrial damage. Cancer Manag Res. 10:5591–5603. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Δ Δ C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Obuchowski NA: ROC analysis. AJR Am J
Roentgenol. 184:364–372. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thomson DW and Dinger ME: Endogenous
microRNA sponges: Evidence and controversy. Nat Rev Genet.
17:272–283. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Du WW, Yang W, Li X, Fang L, Wu N, Li F,
Chen Y, He Q, Liu E, Yang Z, et al: The Circular RNA circSKA3 binds
integrin β1 to induce invadopodium formation enhancing breast
cancer invasion. Mol Ther. 28:1287–1298. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liang G, Ling Y, Mehrpour M, Saw PE, Liu
Z, Tan W, Tian Z, Zhong W, Lin W, Luo Q, et al:
Autophagy-associated circRNA circCDYL augments autophagy and
promotes breast cancer progression. Mol Cancer. 19:652020.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Du Q, Hu B, Feng Y, Wang Z, Wang X, Zhu D,
Zhu Y, Jiang X and Wang H: circOMA1-Mediated miR-145-5p Suppresses
Tumor Growth of Nonfunctioning Pituitary Adenomas by Targeting
TPT1. J Clin Endocrinol Metab. 104:2419–2434. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang H, Huang H, Xu X, Wang H, Wang J,
Yao Z, Xu X, Wu Q and Xu F: LncRNA HCG11 promotes proliferation and
migration in gastric cancer via targeting miR-1276/CTNNB1 and
activating Wnt signaling pathway. Cancer Cell Int. 19:3502019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiong DD, Dang YW, Lin P, Wen DY, He RQ,
Luo DZ, Feng ZB and Chen G: A circRNA-miRNA-mRNA network
identification for exploring underlying pathogenesis and therapy
strategy of hepatocellular carcinoma. J Transl Med. 16:2202018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Afonso-Grunz F and Müller S: Principles of
miRNA-mRNA interactions: Beyond sequence complementarity. Cell Mol
Life Sci. 72:3127–3141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jeong SM, Lee A, Lee J and Haigis MC:
SIRT4 protein suppresses tumor formation in genetic models of
Myc-induced B cell lymphoma. J Biol Chem. 289:4135–4144. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jeong SM, Xiao C, Finley LW, Lahusen T,
Souza AL, Pierce K, Li YH, Wang X, Laurent G, German NJ, et al:
SIRT4 has tumor-suppressive activity and regulates the cellular
metabolic response to DNA damage by inhibiting mitochondrial
glutamine metabolism. Cancer Cell. 23:450–463. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fu L, Dong Q, He J, Wang X, Xing J, Wang
E, Qiu X and Li Q: SIRT4 inhibits malignancy progression of NSCLCs,
through mitochondrial dynamics mediated by the ERK-Drp1 pathway.
Oncogene. 36:2724–2736. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Miyo M, Yamamoto H, Konno M, Colvin H,
Nishida N, Koseki J, Kawamoto K, Ogawa H, Hamabe A, Uemura M, et
al: Tumour-suppressive function of SIRT4 in human colorectal
cancer. Br J Cancer. 113:492–499. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nakahara Y, Yamasaki M, Sawada G, Miyazaki
Y, Makino T, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S,
Mimori K, et al: Downregulation of SIRT4 Expression Is Associated
with Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Oncology. 90:347–355. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang G, Lin Y and Zhu G: SIRT4 is
upregulated in breast cancer and promotes the proliferation,
migration and invasion of breast cancer cells. Int J Clin Exp
Pathol. 10:11849–11856. 2017.PubMed/NCBI
|
